Latest Insider Transactions at John Bean Technologies Corp (JBT)
This section provides a real-time view of insider transactions for John Bean Technologies Corp (JBT). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of John Bean Technologies CORP to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of John Bean Technologies CORP's insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Feb 24
2022
|
Shelley Rae Bridarolli EVP, Human Resources |
BUY
Grant, award, or other acquisition
|
Direct |
1,530
+34.33%
|
-
|
Feb 24
2022
|
David C Burdakin EVP & President, JBT AeroTech |
BUY
Grant, award, or other acquisition
|
Direct |
2,122
+2.58%
|
-
|
Feb 24
2022
|
Jessi L Corcoran VP, Corporate Controller & CAO |
BUY
Grant, award, or other acquisition
|
Direct |
410
+12.26%
|
-
|
Feb 24
2022
|
Brian A Deck President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
12,779
+7.58%
|
-
|
Feb 24
2022
|
Carlos Fernandez EVP & President, DF&H |
BUY
Grant, award, or other acquisition
|
Direct |
2,277
+4.42%
|
-
|
Feb 24
2022
|
James L Marvin EVP & General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
2,032
+6.59%
|
-
|
Feb 24
2022
|
Matthew J Meister Executive VP & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
2,556
+15.3%
|
-
|
Feb 24
2022
|
Kristina L Paschall EVP, CIO & CDO |
BUY
Grant, award, or other acquisition
|
Direct |
1,386
+17.24%
|
-
|
Feb 24
2022
|
Robert James Petrie EVP & President, Protein |
BUY
Grant, award, or other acquisition
|
Direct |
1,806
+15.22%
|
-
|
Feb 18
2022
|
Caroline Maury Devine Director |
SELL
Open market or private sale
|
Direct |
300
-0.62%
|
$39,300
$131.21 P/Share
|
Jan 18
2022
|
Caroline Maury Devine Director |
SELL
Open market or private sale
|
Direct |
300
-0.62%
|
$44,100
$147.49 P/Share
|
Jan 03
2022
|
Charles L. Harrington Director |
BUY
Grant, award, or other acquisition
|
Direct |
427
+50.0%
|
-
|
Jan 03
2022
|
Carlos Fernandez EVP & President, DF&H |
SELL
Open market or private sale
|
Direct |
477
-2.12%
|
$72,981
$153.66 P/Share
|
Dec 20
2021
|
Caroline Maury Devine Director |
SELL
Open market or private sale
|
Direct |
300
-0.61%
|
$44,400
$148.53 P/Share
|
Nov 26
2021
|
Bryant K Lowery EVP, COO & CPO |
SELL
Payment of exercise price or tax liability
|
Direct |
522
-9.37%
|
$85,086
$163.36 P/Share
|
Nov 18
2021
|
Caroline Maury Devine Director |
SELL
Open market or private sale
|
Direct |
300
-0.61%
|
$50,700
$169.22 P/Share
|
Nov 10
2021
|
Carlos Fernandez EVP & President, DF&H |
SELL
Open market or private sale
|
Direct |
1,000
-4.26%
|
$170,000
$170.73 P/Share
|
Nov 10
2021
|
James M Ringler Director |
SELL
Open market or private sale
|
Direct |
1,669
-3.57%
|
$283,730
$170.49 P/Share
|
Oct 18
2021
|
Caroline Maury Devine Director |
SELL
Open market or private sale
|
Direct |
300
-0.61%
|
$44,400
$148.21 P/Share
|
Oct 15
2021
|
James L Marvin EVP & General Counsel |
SELL
Open market or private sale
|
Direct |
2,500
-17.23%
|
$372,500
$149.87 P/Share
|
Oct 07
2021
|
Shelley Rae Bridarolli EVP, Human Resources |
BUY
Grant, award, or other acquisition
|
Direct |
1,397
+50.0%
|
-
|
Sep 20
2021
|
Caroline Maury Devine Director |
SELL
Open market or private sale
|
Direct |
300
-0.6%
|
$44,700
$149.83 P/Share
|
Aug 18
2021
|
Caroline Maury Devine Director |
SELL
Open market or private sale
|
Direct |
300
-0.6%
|
$41,400
$138.38 P/Share
|
Jul 19
2021
|
Caroline Maury Devine Director |
SELL
Open market or private sale
|
Direct |
300
-0.6%
|
$39,300
$131.22 P/Share
|
Jul 15
2021
|
James L Marvin EVP & General Counsel |
SELL
Open market or private sale
|
Direct |
2,500
-14.7%
|
$330,000
$132.5 P/Share
|
Jun 23
2021
|
Brian A Deck President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,835
-2.93%
|
$249,560
$136.67 P/Share
|
Jun 18
2021
|
Caroline Maury Devine Director |
SELL
Open market or private sale
|
Direct |
300
-0.59%
|
$39,600
$132.85 P/Share
|
May 03
2021
|
Polly B Kawalek Director |
SELL
Open market or private sale
|
Direct |
1,800
-2.59%
|
$261,000
$145.56 P/Share
|
May 01
2021
|
Barbara L Brasier Director |
BUY
Grant, award, or other acquisition
|
Direct |
825
+18.75%
|
-
|
May 01
2021
|
Caroline Maury Devine Director |
BUY
Grant, award, or other acquisition
|
Direct |
825
+1.6%
|
-
|
May 01
2021
|
Alan D Feldman Director |
BUY
Grant, award, or other acquisition
|
Direct |
825
+1.38%
|
-
|
May 01
2021
|
James E Goodwin Director |
BUY
Grant, award, or other acquisition
|
Direct |
825
+1.55%
|
-
|
May 01
2021
|
Lawrence V Jackson Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,100
+25.02%
|
-
|
May 01
2021
|
Polly B Kawalek Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,375
+1.94%
|
-
|
May 01
2021
|
Emmanuel Lagarrigue Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,375
+18.9%
|
-
|
May 01
2021
|
James M Ringler Director |
BUY
Grant, award, or other acquisition
|
Direct |
825
+1.74%
|
-
|
Apr 28
2021
|
Paul Sternlieb EVP & President, Protein |
SELL
Open market or private sale
|
Direct |
2,644
-19.43%
|
$383,380
$145.0 P/Share
|
Apr 15
2021
|
James L Marvin EVP & General Counsel |
SELL
Open market or private sale
|
Direct |
2,500
-12.82%
|
$337,500
$135.15 P/Share
|
Apr 15
2021
|
Jason T Clayton EVP, Human Resources |
SELL
Open market or private sale
|
Direct |
1,689
-19.71%
|
$228,015
$135.15 P/Share
|
Apr 01
2021
|
David C Burdakin EVP & President, JBT AeroTech |
SELL
Payment of exercise price or tax liability
|
Direct |
1,361
-1.72%
|
$183,735
$135.9 P/Share
|
Apr 01
2021
|
Jason T Clayton EVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
899
-4.87%
|
$121,365
$135.9 P/Share
|
Apr 01
2021
|
Jessi L Corcoran VP, Corporate Controller & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
88
-4.29%
|
$11,880
$135.9 P/Share
|
Apr 01
2021
|
Brian A Deck President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,060
-1.61%
|
$278,100
$135.9 P/Share
|
Apr 01
2021
|
Carlos Fernandez EVP & President, DF&H |
SELL
Payment of exercise price or tax liability
|
Direct |
1,127
-2.32%
|
$152,145
$135.9 P/Share
|
Apr 01
2021
|
James L Marvin EVP & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
948
-2.34%
|
$127,980
$135.9 P/Share
|
Apr 01
2021
|
Kristina L Paschall EVP, CIO & CDO |
SELL
Payment of exercise price or tax liability
|
Direct |
187
-5.64%
|
$25,245
$135.9 P/Share
|
Apr 01
2021
|
Paul Sternlieb EVP & President, Protein |
SELL
Payment of exercise price or tax liability
|
Direct |
1,267
-4.35%
|
$171,045
$135.9 P/Share
|
Mar 17
2021
|
Caroline Maury Devine Director |
SELL
Open market or private sale
|
Direct |
236
-0.47%
|
$32,804
$139.36 P/Share
|
Mar 01
2021
|
David C Burdakin EVP & President, JBT AeroTech |
SELL
Open market or private sale
|
Direct |
4,000
-3.11%
|
$600,000
$150.35 P/Share
|
Feb 25
2021
|
David C Burdakin EVP & President, JBT AeroTech |
BUY
Grant, award, or other acquisition
|
Direct |
2,929
+3.27%
|
-
|